January 09, 2014
Kristie Blum, MD, an associate professor in the Division of Hematology at Ohio State and a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, will be the keynote speaker at Ohio State’s 2014 ASH Review, which will unfold from 7:30 a.m.-4 p.m. on Friday, Jan. 31, in Room 115 of the Biomedical Research Tower. Blum is an expert in novel therapies for lymphoma, particularly the targeted agent ibrutinib.
The annual conference will provide a comprehensive review of advances in the biology, etiology, diagnosis, therapy and evidence-based management of blood cancers as presented at the 2013 American Society of Hematology (ASH) annual meeting held Dec. 7-10 in New Orleans. The ASH review is intended for primary care physicians, hematologists and oncologists, researchers, nurses and other healthcare professionals involved in hematology.
There is no fee to attend, but registration is required at go.osu.edu/ASHREVIEW. Questions? Contact Katie Jones at email@example.com of 366-5183.
The rest of the story